Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.22.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of product warranty accrual
           
    March 31,
2022
    December 31,
2021
 
             
Beginning balance   $ 46,650     $ 17,551  
Warranty claims incurred     (700 )     (1,527
Provision charged (credited) to expense     5,468       30,626  
Ending balance   $ 51,418     $ 46,650  
Schedule of earnings per share
           
    2022     2021  
Net loss   $ (517,828 )   $ 82,739  
Less: cumulative dividends earned on Series A and Series B preferred stock     (23,388 )     (23,502 )
Net loss attributable to common shareholders   $ (541,216 )   $ 59,237  
Schedule of weighted average diluted shares
           
    2022     2021  
Weighted average common shares outstanding - basic     286,542,208       136,311,335  
Dilutive effect of stock options            
Dilutive effect of stock warrants            
Weighted average common shares outstanding - diluted     286,542,208       136,311,335